VolitionRX Limited (VNRX): Price and Financial Metrics

VolitionRX Limited (VNRX): $0.62

0.02 (+3.89%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

VNRX Price/Volume Stats

Current price $0.62 52-week high $2.10
Prev. close $0.59 52-week low $0.55
Day low $0.60 Volume 255,700
Day high $0.65 Avg. volume 176,536
50-day MA $0.89 Dividend yield N/A
200-day MA $0.96 Market Cap 50.65M

VNRX Stock Price Chart Interactive Chart >


VolitionRX Limited (VNRX) Company Bio


VolitionRX Limited, a clinical-stage life sciences company, focuses on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is based in Singapore.


VNRX Latest News Stream


Event/Time News Detail
Loading, please wait...

VNRX Latest Social Stream


Loading social stream, please wait...

View Full VNRX Social Stream

Latest VNRX News From Around the Web

Below are the latest news stories about VOLITIONRX LTD that investors may wish to consider to help them evaluate VNRX as an investment opportunity.

Sidoti Events, LLC's Virtual December Small-Cap Conference

NEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December ...

Yahoo | December 5, 2023

VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has closed on an aggregate of Euro 5.0 million (approximately $5.5 million) in financing from Wallonie Entreprendre S.A. ("WE") in Belgium.

Yahoo | December 5, 2023

VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript

VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript November 15, 2023 Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited Third Quarter 2023 Earnings Conference Call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be opened for questions. [Operator […]

Yahoo | November 16, 2023

VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update

VolitionRx Limited (NYSE American: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended September 30, 2023. Volition management will host a conference call tomorrow, November 15 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below.

Yahoo | November 14, 2023

VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Wednesday, November 15 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter 2023, in addition to providing a business update. Details of this event can also be found below.

Yahoo | November 8, 2023

Read More 'VNRX' Stories Here

VNRX Price Returns

1-mo -22.50%
3-mo -37.55%
6-mo -20.23%
1-year -63.53%
3-year -80.38%
5-year -81.71%
YTD -13.53%
2023 -70.49%
2022 -22.61%
2021 -19.28%
2020 -17.93%
2019 161.88%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!